Browsing by Department PHARMACY

Select a letter below to start browsing or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 1901 to 1916 of 1916 < previous 
Issue DateTitleAuthor(s)
2006Water-soluble polysaccharides of Ganoderma lucidum (W.Curt.:Fr.) P. Karst. (Aphyllophoromycetideae) alleviate the dose-limiting toxicities of irinotecan (CPT-11)Hu, Z.; Chen, X.; Yang, X.; Gao, Y.; Zhou, S. 
2004Wet Spheronization by Rotary Processing - A Multistage Single-Pot Process for Producing SpheroidsGu, L.; Liew, C.V. ; Heng, P.W.S. 
Jul-2009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targetsZhu, F. ; Han, L. ; Zheng, C. ; Xie, B.; Tammi, M.T. ; Yang, S.; Wei, Y.; Chen, Y. 
2009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targetsZhu, F. ; Han, L. ; Zheng, C.; Xie, B.; Chen, Y. ; Tammi, M.T. ; Yang, S.; Wei, Y.
Jul-2009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targets.Zhu, F. ; Han, L. ; Zheng, C. ; Xie, B.; Tammi, M.T. ; Yang, S.; Wei, Y.; Chen, Y. 
2009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targets.Zhu, F. ; Han, L. ; Zheng, C.; Xie, B.; Tammi, M.T. ; Yang, S.; Wei, Y.; Chen, Y. 
28-Nov-2012What Does It Take to Synergistically Combine Sub-Potent Natural Products into Drug-Level Potent Combinations?Qin, C.; Tan, K.L.; Zhang, C.L.; Tan, C.Y.; Chen, Y.Z. ; Jiang, Y.Y.
Mar-2006What health domains and items are important to patients with knee osteoarthritis? A focus group study in a multiethnic urban Asian populationXie, F.; Li, S.-C. ; Fong, K.-Y.; Lo, N.N.; Yeo, S.-J.; Yang, K.-Y.; Thumboo, J.
2006What health domains and items are important to patients with knee osteoarthritis? A focus group study in a multiethnic urban Asian populationXie, F. ; Li, S.-C. ; Fong, K.-Y. ; Thumboo, J. ; Lo, N.N.; Yeo, S.-J.; Yang, K.-Y.
Mar-2004What Is Next for Pharmacoeconomics and Outcomes Research in Asia?Doherty, J.; Kamae, I.; Lee, K.K.C.; Li, H.; Li, S.-C. ; Liu, G.G.; Tarn, Y.-H.; Yang, B.-M.
15-Nov-2010Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cellsWang, C.; Ho, P.C. ; Lim, L.Y.
21-Feb-2005Wheat germ agglutinin-conjugated PLGA nanoparticles for the delivery of paclitaxelMO YUN
29-Oct-2009Wheat germ agglutinin-conjugated poly-dl-lactic-co-glycolic acid (PLGA) nanoparticles for enhanced uptake and retention of paclitaxel by colon cancer cellsWANG CHUNXIA
2013Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general publicChan, S.L.; Wen Low, J.J.; Lim, Y.W.; Finkelstein, E.; Farooqui, M.A.; Chia, K.S. ; Wee, H.L. 
May-2011Zebrafish for drug toxicity screening: Bridging the in vitro cell-based models and in vivo mammalian modelsSukardi, H.; Chng, H.T.; Chan, E.C.Y. ; Gong, Z. ; Lam, S.H. 
Mar-2010β-amyrin from Ardisia elliptica Thunb. Is more potent than aspirin in inhibiting collagen-induced platelet aggregationChing, J.; Chua, T.-K.; Chin, L.-C.; Lau, A.-J. ; Pang, Y.-K.; Jaya, J.M.; Tan, C.-H.; Koh, H.-L.